Alarum director reports indirect holdings, options
Alarum Technologies director Rubinstein Avraham filed an initial ownership report showing indirect stakes in the company.
Rhea-AI Filing Summary
Alarum Technologies director Rubinstein Avraham filed an initial ownership report showing indirect stakes in the company. He is reported as indirectly holding 225,000 Ordinary Shares and stock options over 34,808 Ordinary Shares at an exercise price of $0.484 per share, expiring on November 8, 2029. The Ordinary Share figure includes 125,000 shares issuable from RSUs vesting in quarterly installments through July 19, 2028. These securities are owned by Ilanor Ltd., in which Mr. Rubinstein’s spouse indirectly owns 49.9%, and he disclaims beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (4)
- F1. Includes (i) 18,750 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through October 19, 2026 in 3 equal quarterly installments of 6,250 Ordinary Shares; (ii) 43,750 Ordinary Shares, issuable upon the vesting of RSUs, through October 19, 2027 in 7 equal quarterly installments of 6,250 Ordinary Shares; and (iii) 62,500 Ordinary Shares, issuable upon the vesting of RSUs, through July 19, 2028 in 10 equal quarterly installments of 6,250 Ordinary Shares. Each RSU represents the right to receive one Ordinary Share.
- F2. The securities are owned by Ilanor Ltd. ("Ilanor"). Mr. Rubinstein spouse indirectly owns 49.9% in Ilanor, and, therefore, Mr. Rubinstein may be deemed to beneficially own securities owned by Ilanor, to the extent of his spouse's pecuniary interest therein. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3. The options were granted with an exercise price of NIS 1.510 and have been converted based on the ratio of $0.484 as of March 16, 2026.
- F4. The options were granted on November 8, 2022, and fully vested as of November 8, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider holdings did Rubinstein Avraham report in Alarum (ALAR) Form 3?
What RSU vesting schedule is disclosed for Alarum (ALAR) in this Form 3?
What are the key terms of Rubinstein Avraham’s Alarum (ALAR) stock options?
Does Rubinstein Avraham fully own all reported Alarum (ALAR) securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.